Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.8 USD 1.6% Market Closed
Market Cap: 41m USD

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Lowest
Price Target
18.18 USD
378% Upside
Average
Price Target
22.44 USD
491% Upside
Highest
Price Target
27.3 USD
618% Upside
Lantern Pharma Inc. Competitors:
Price Targets
TSHA
Taysha Gene Therapies Inc
291% Upside
INMB
INmune Bio Inc
200% Upside
CCCC
C4 Therapeutics Inc
704% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
42% Upside
ANAB
AnaptysBio Inc
126% Upside
BIIB
Biogen Inc
45% Upside
ORGO
Organogenesis Holdings Inc
12% Upside
QURE
Uniqure NV
163% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Back to Top